PPAR α gene is a diagnostic and prognostic biomarker in clear cell renal cell carcinoma by integrated bioinformatics analysis

In conclusion, PPARα expression was decreased in ccRCC tumors. Lower expression of PPARα is closely correlated with poorer survival. It can be used as a clinically diagnosis and prognostic biomarker in ccRCC.

Source: Journal of Cancer - June 13, 2019 Category: Cancer & Oncology Authors: Yongwen Luo, Liang Chen, Gang Wang, Guofeng Qian, Xuefeng Liu, Yu Xiao, Xinghuan Wang, Kaiyu Qian Tags: Research Paper Source Type: research